SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-23-000019
Filing Date
2023-08-10
Accepted
2023-08-10 16:02:02
Documents
66
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sls-20230630.htm   iXBRL 10-Q 769285
2 EX-10.1 sls-20230630ex101.htm EX-10.1 134197
3 EX-10.2 sls-20230630ex102.htm EX-10.2 37462
4 EX-31.1 sls-20230630ex311.htm EX-31.1 8218
5 EX-31.2 sls-20230630ex312.htm EX-31.2 8206
6 EX-32.1 sls-20230630ex321.htm EX-32.1 6580
7 EX-32.2 sls-20230630ex322.htm EX-32.2 6570
13 sls-20230630_g1.jpg GRAPHIC 30719
  Complete submission text file 0001390478-23-000019.txt   4762740

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sls-20230630.xsd EX-101.SCH 39512
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sls-20230630_cal.xml EX-101.CAL 48165
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sls-20230630_def.xml EX-101.DEF 141157
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sls-20230630_lab.xml EX-101.LAB 453289
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sls-20230630_pre.xml EX-101.PRE 294603
60 EXTRACTED XBRL INSTANCE DOCUMENT sls-20230630_htm.xml XML 554668
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 231159156
SIC: 2834 Pharmaceutical Preparations